127 related articles for article (PubMed ID: 9222293)
1. Immunization against platelet glycoprotein IIb-IIIa in Glanzmann's thrombasthenia.
Taaning E; Knudsen FU; Thorsen S; Jønsson V
Eur J Haematol; 1997 May; 58(5):360-1. PubMed ID: 9222293
[No Abstract] [Full Text] [Related]
2. Protein A Sepharose immunoadsorption can restore the efficacy of platelet concentrates in patients with Glanzmann's thrombasthenia and anti-glycoprotein IIb-IIIa antibodies.
Martin I; Kriaa F; Proulle V; Guillet B; Kaplan C; D'Oiron R; Debré M; Fressinaud E; Laurian Y; Tchernia G; Charpentier B; Lambert T; Dreyfus M
Br J Haematol; 2002 Dec; 119(4):991-7. PubMed ID: 12472579
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow transplantation in severe Glanzmann's thrombasthenia with antiplatelet alloimmunization.
Bellucci S; Damaj G; Boval B; Rocha V; Devergie A; Yacoub-Agha I; Garderet L; Ribaud P; Traineau R; Socié G; Gluckman E
Bone Marrow Transplant; 2000 Feb; 25(3):327-30. PubMed ID: 10673707
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy in mother with Glanzmann's thrombasthenia and isoantibody against GPIIb-IIIa: Is there a foetal risk?
Léticée N; Kaplan C; Lémery D
Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):139-42. PubMed ID: 16054952
[TBL] [Abstract][Full Text] [Related]
5. Platelet transfusion in a patient affected by Glanzmann's thrombasthenia with antibodies against GPIIb-IIIa.
Conte R; Cirillo D; Ricci F; Tassi C; Tazzari PL
Haematologica; 1997; 82(1):73-4. PubMed ID: 9107089
[TBL] [Abstract][Full Text] [Related]
6. Immunisation against αIIbβ3 and αvβ3 in a type 1 variant of Glanzmann's thrombasthenia caused by a missense mutation Gly540Asp on β3.
Wihadmadyatami H; Röder L; Berghöfer H; Bein G; Heidinger K; Sachs UJ; Santoso S
Thromb Haemost; 2016 Aug; 116(2):262-71. PubMed ID: 27098940
[TBL] [Abstract][Full Text] [Related]
7. Different biochemical expression pattern of platelet surface glycoproteins suggests molecular diversity of Glanzmann's thrombasthenia in Iran.
Farsinejad A; Farajollahi MM; Kazemi A; Saemi N; Faranoush M
Blood Coagul Fibrinolysis; 2013 Sep; 24(6):613-8. PubMed ID: 23912132
[TBL] [Abstract][Full Text] [Related]
8. A variant of Glanzmann's thrombasthenia characterized by abnormal glycoprotein IIb/IIIa complex formation.
Fournier DJ; Kabral A; Castaldi PA; Berndt MC
Thromb Haemost; 1989 Nov; 62(3):977-83. PubMed ID: 2512684
[TBL] [Abstract][Full Text] [Related]
9. Acquired Glanzmann's thrombasthenia caused by glycoprotein IIb/IIIa autoantibodies of the immunoglobulin G1 (IgG1), IgG2 or IgG4 subclass: a study in six cases.
Porcelijn L; Huiskes E; Maatman R; de Kreuk A; de Haas M
Vox Sang; 2008 Nov; 95(4):324-30. PubMed ID: 19138263
[TBL] [Abstract][Full Text] [Related]
10. [Molecular pathology of inherited Glanzmann's thrombasthenia. Report of 11 cases].
Ruan CG; Gu JM; Li JY
Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):639-41, 659. PubMed ID: 1306460
[TBL] [Abstract][Full Text] [Related]
11. Acquired Glanzmann's thrombasthenia: Diagnosis aided by platelet aggregation mixing study.
Compton F; Sarode R; Rutherford C; Curtis B; De Simone N
Haemophilia; 2020 Mar; 26(2):e41-e43. PubMed ID: 31985103
[No Abstract] [Full Text] [Related]
12. Triple jeopardy: A case of Glanzmann's thrombasthenia with anti-GPIIb-IIIa antibodies and HPA incompatibility resulting in stillbirth.
Soni P; Mantri S; Prabhudesai A; Patil R; Shanmukhaiah C; Shetty S
Thromb Res; 2019 Sep; 181():141-144. PubMed ID: 31404847
[No Abstract] [Full Text] [Related]
13. Decreased stability and structural heterogeneity of the residual platelet glycoprotein IIb/IIIa complex in a variant of Glanzmann's thrombasthenia.
Modderman PW; van Mourik JA; van Berkel W; Cordell JL; Morel MC; Kaplan C; Ouwehand WH; Huisman JG; von dem Borne AE
Br J Haematol; 1989 Dec; 73(4):514-21. PubMed ID: 2611137
[TBL] [Abstract][Full Text] [Related]
14. Identification of Clinicopathological Spectrum, Platelet Glycoprotein IIb/IIIa complex and Platelet Antibodies in Egyptian Children with Glanzmann's Thrombasthenia.
Zahran AM; Saad K; Elsayh KI; Alblihed MA; Embaby M
Arch Immunol Ther Exp (Warsz); 2017 Dec; 65(6):565-571. PubMed ID: 28161816
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of Glanzmann's thrombasthenia in Iran: identification of three novel mutations.
Kazemi A; Abolghasemi H; Kazemzadeh S; Vahidi R; Faranoush M; Farsinejad A; Ala F
Blood Coagul Fibrinolysis; 2017 Dec; 28(8):681-686. PubMed ID: 29084015
[TBL] [Abstract][Full Text] [Related]
16. Norethisterone therapy for bleeding due to gastrointestinal telangiectases in Glanzmann's thrombasthenia.
Leach M; Makris M; Hampton KK; Preston FE
Br J Haematol; 1998 Mar; 100(3):594-6. PubMed ID: 9504647
[TBL] [Abstract][Full Text] [Related]
17. Clinical spectrum of Glanzmann's thrombasthenia.
Badhe BA; Jayanthi S; Datta T
Indian J Pathol Microbiol; 2000 Jul; 43(3):297-302. PubMed ID: 11218676
[TBL] [Abstract][Full Text] [Related]
18. [Fc receptor-dependent platelet activation results independently of glycoprotein complex IIb/IIIa].
Greinacher A; Liebenhoff U; Kiefel V; Presek P; Mueller-Eckhardt C
Beitr Infusionsther Transfusionsmed; 1994; 32():208-10. PubMed ID: 9480089
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of platelet fibrinogen and thrombospondin in Glanzmann's thrombasthenia by electroimmunoassay.
Disdier M; Legrand C; Bouillot C; Dubernard V; Pidard D; Nurden AT
Thromb Res; 1989 Mar; 53(6):521-33. PubMed ID: 2499944
[TBL] [Abstract][Full Text] [Related]
20. [Glanzmann's thrombasthenia: a rare example of an integrin deficit].
Perutelli P; Mori PG
Recenti Prog Med; 1992 Oct; 83(10):577-81. PubMed ID: 1462042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
